Global Human Tuberculosis Vaccine Market Growth 2022-2028
The global market for Human Tuberculosis Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Human Tuberculosis Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Human Tuberculosis Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Human Tuberculosis Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Human Tuberculosis Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Human Tuberculosis Vaccine players cover GlaxoSmithKline, Merck, Serum Institute of India, Valneva and Archivel Farma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Human Tuberculosis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Human Tuberculosis Vaccine market, with both quantitative and qualitative data, to help readers understand how the Human Tuberculosis Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Human Tuberculosis Vaccine market and forecasts the market size by Type (Intradermal and Percutaneous,), by Application (Pediatrics and Adults.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Intradermal
Percutaneous
Segmentation by application
Pediatrics
Adults
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GlaxoSmithKline
Merck
Serum Institute of India
Valneva
Archivel Farma
BIOFABRI (Zendal)
Japan BCG Laboratory
GreenSignal Bio Pharma
AJ Vaccines
Taj Pharma India
Biomed Lublin
Chapter Introduction
Chapter 1: Scope of Human Tuberculosis Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Human Tuberculosis Vaccine market size (sales and revenue) and CAGR, Human Tuberculosis Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Human Tuberculosis Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Human Tuberculosis Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Human Tuberculosis Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline, Merck, Serum Institute of India, Valneva, Archivel Farma, BIOFABRI (Zendal), Japan BCG Laboratory, GreenSignal Bio Pharma and AJ Vaccines, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Tuberculosis Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Tuberculosis Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Tuberculosis Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Human Tuberculosis Vaccine Segment by Type
2.2.1 Intradermal
2.2.2 Percutaneous
2.3 Human Tuberculosis Vaccine Sales by Type
2.3.1 Global Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Human Tuberculosis Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Tuberculosis Vaccine Sale Price by Type (2017-2022)
2.4 Human Tuberculosis Vaccine Segment by Application
2.4.1 Pediatrics
2.4.2 Adults
2.5 Human Tuberculosis Vaccine Sales by Application
2.5.1 Global Human Tuberculosis Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Human Tuberculosis Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Tuberculosis Vaccine Sale Price by Application (2017-2022)
3 Global Human Tuberculosis Vaccine by Company
3.1 Global Human Tuberculosis Vaccine Breakdown Data by Company
3.1.1 Global Human Tuberculosis Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Human Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Human Tuberculosis Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Human Tuberculosis Vaccine Revenue by Company (2020-2022)
3.2.2 Global Human Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Human Tuberculosis Vaccine Sale Price by Company
3.4 Key Manufacturers Human Tuberculosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Tuberculosis Vaccine Product Location Distribution
3.4.2 Players Human Tuberculosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Tuberculosis Vaccine by Geographic Region
4.1 World Historic Human Tuberculosis Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Tuberculosis Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Tuberculosis Vaccine Annual Revenue by Geographic Region
4.2 World Historic Human Tuberculosis Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Human Tuberculosis Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Tuberculosis Vaccine Annual Revenue by Country/Region
4.3 Americas Human Tuberculosis Vaccine Sales Growth
4.4 APAC Human Tuberculosis Vaccine Sales Growth
4.5 Europe Human Tuberculosis Vaccine Sales Growth
4.6 Middle East & Africa Human Tuberculosis Vaccine Sales Growth
5 Americas
5.1 Americas Human Tuberculosis Vaccine Sales by Country
5.1.1 Americas Human Tuberculosis Vaccine Sales by Country (2017-2022)
5.1.2 Americas Human Tuberculosis Vaccine Revenue by Country (2017-2022)
5.2 Americas Human Tuberculosis Vaccine Sales by Type
5.3 Americas Human Tuberculosis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Tuberculosis Vaccine Sales by Region
6.1.1 APAC Human Tuberculosis Vaccine Sales by Region (2017-2022)
6.1.2 APAC Human Tuberculosis Vaccine Revenue by Region (2017-2022)
6.2 APAC Human Tuberculosis Vaccine Sales by Type
6.3 APAC Human Tuberculosis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Tuberculosis Vaccine by Country
7.1.1 Europe Human Tuberculosis Vaccine Sales by Country (2017-2022)
7.1.2 Europe Human Tuberculosis Vaccine Revenue by Country (2017-2022)
7.2 Europe Human Tuberculosis Vaccine Sales by Type
7.3 Europe Human Tuberculosis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Tuberculosis Vaccine by Country
8.1.1 Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Tuberculosis Vaccine Sales by Type
8.3 Middle East & Africa Human Tuberculosis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Tuberculosis Vaccine
10.3 Manufacturing Process Analysis of Human Tuberculosis Vaccine
10.4 Industry Chain Structure of Human Tuberculosis Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Tuberculosis Vaccine Distributors
11.3 Human Tuberculosis Vaccine Customer
12 World Forecast Review for Human Tuberculosis Vaccine by Geographic Region
12.1 Global Human Tuberculosis Vaccine Market Size Forecast by Region
12.1.1 Global Human Tuberculosis Vaccine Forecast by Region (2023-2028)
12.1.2 Global Human Tuberculosis Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Tuberculosis Vaccine Forecast by Type
12.7 Global Human Tuberculosis Vaccine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Human Tuberculosis Vaccine Product Offered
13.1.3 GlaxoSmithKline Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Human Tuberculosis Vaccine Product Offered
13.2.3 Merck Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Human Tuberculosis Vaccine Product Offered
13.3.3 Serum Institute of India Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 Valneva
13.4.1 Valneva Company Information
13.4.2 Valneva Human Tuberculosis Vaccine Product Offered
13.4.3 Valneva Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Valneva Main Business Overview
13.4.5 Valneva Latest Developments
13.5 Archivel Farma
13.5.1 Archivel Farma Company Information
13.5.2 Archivel Farma Human Tuberculosis Vaccine Product Offered
13.5.3 Archivel Farma Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Archivel Farma Main Business Overview
13.5.5 Archivel Farma Latest Developments
13.6 BIOFABRI (Zendal)
13.6.1 BIOFABRI (Zendal) Company Information
13.6.2 BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Offered
13.6.3 BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BIOFABRI (Zendal) Main Business Overview
13.6.5 BIOFABRI (Zendal) Latest Developments
13.7 Japan BCG Laboratory
13.7.1 Japan BCG Laboratory Company Information
13.7.2 Japan BCG Laboratory Human Tuberculosis Vaccine Product Offered
13.7.3 Japan BCG Laboratory Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Japan BCG Laboratory Main Business Overview
13.7.5 Japan BCG Laboratory Latest Developments
13.8 GreenSignal Bio Pharma
13.8.1 GreenSignal Bio Pharma Company Information
13.8.2 GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Offered
13.8.3 GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GreenSignal Bio Pharma Main Business Overview
13.8.5 GreenSignal Bio Pharma Latest Developments
13.9 AJ Vaccines
13.9.1 AJ Vaccines Company Information
13.9.2 AJ Vaccines Human Tuberculosis Vaccine Product Offered
13.9.3 AJ Vaccines Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AJ Vaccines Main Business Overview
13.9.5 AJ Vaccines Latest Developments
13.10 Taj Pharma India
13.10.1 Taj Pharma India Company Information
13.10.2 Taj Pharma India Human Tuberculosis Vaccine Product Offered
13.10.3 Taj Pharma India Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Taj Pharma India Main Business Overview
13.10.5 Taj Pharma India Latest Developments
13.11 Biomed Lublin
13.11.1 Biomed Lublin Company Information
13.11.2 Biomed Lublin Human Tuberculosis Vaccine Product Offered
13.11.3 Biomed Lublin Human Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Biomed Lublin Main Business Overview
13.11.5 Biomed Lublin Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Human Tuberculosis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Tuberculosis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intradermal
Table 4. Major Players of Percutaneous
Table 5. Global Human Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Human Tuberculosis Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Human Tuberculosis Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Human Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Human Tuberculosis Vaccine Revenue by Application (2017-2022)
Table 13. Global Human Tuberculosis Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Human Tuberculosis Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Human Tuberculosis Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Human Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Human Tuberculosis Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Human Tuberculosis Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Human Tuberculosis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Human Tuberculosis Vaccine Products Offered
Table 22. Human Tuberculosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Tuberculosis Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Human Tuberculosis Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Tuberculosis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Tuberculosis Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Tuberculosis Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Human Tuberculosis Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Tuberculosis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Tuberculosis Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Human Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Human Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Human Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Human Tuberculosis Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Human Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Human Tuberculosis Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Tuberculosis Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Human Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Human Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Human Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Human Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Human Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Tuberculosis Vaccine
Table 66. Key Market Challenges & Risks of Human Tuberculosis Vaccine
Table 67. Key Industry Trends of Human Tuberculosis Vaccine
Table 68. Human Tuberculosis Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Tuberculosis Vaccine Distributors List
Table 71. Human Tuberculosis Vaccine Customer List
Table 72. Global Human Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Human Tuberculosis Vaccine Sales Market Forecast by Region
Table 74. Global Human Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Tuberculosis Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Human Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Human Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Human Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Human Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Tuberculosis Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Tuberculosis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Tuberculosis Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Tuberculosis Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Human Tuberculosis Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Tuberculosis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Tuberculosis Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. GlaxoSmithKline Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline Human Tuberculosis Vaccine Product Offered
Table 94. GlaxoSmithKline Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Latest Developments
Table 97. Merck Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Human Tuberculosis Vaccine Product Offered
Table 99. Merck Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Serum Institute of India Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Serum Institute of India Human Tuberculosis Vaccine Product Offered
Table 104. Serum Institute of India Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Serum Institute of India Main Business
Table 106. Serum Institute of India Latest Developments
Table 107. Valneva Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Valneva Human Tuberculosis Vaccine Product Offered
Table 109. Valneva Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Valneva Main Business
Table 111. Valneva Latest Developments
Table 112. Archivel Farma Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Archivel Farma Human Tuberculosis Vaccine Product Offered
Table 114. Archivel Farma Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Archivel Farma Main Business
Table 116. Archivel Farma Latest Developments
Table 117. BIOFABRI (Zendal) Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. BIOFABRI (Zendal) Human Tuberculosis Vaccine Product Offered
Table 119. BIOFABRI (Zendal) Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. BIOFABRI (Zendal) Main Business
Table 121. BIOFABRI (Zendal) Latest Developments
Table 122. Japan BCG Laboratory Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Japan BCG Laboratory Human Tuberculosis Vaccine Product Offered
Table 124. Japan BCG Laboratory Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Japan BCG Laboratory Main Business
Table 126. Japan BCG Laboratory Latest Developments
Table 127. GreenSignal Bio Pharma Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. GreenSignal Bio Pharma Human Tuberculosis Vaccine Product Offered
Table 129. GreenSignal Bio Pharma Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. GreenSignal Bio Pharma Main Business
Table 131. GreenSignal Bio Pharma Latest Developments
Table 132. AJ Vaccines Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. AJ Vaccines Human Tuberculosis Vaccine Product Offered
Table 134. AJ Vaccines Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. AJ Vaccines Main Business
Table 136. AJ Vaccines Latest Developments
Table 137. Taj Pharma India Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Taj Pharma India Human Tuberculosis Vaccine Product Offered
Table 139. Taj Pharma India Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Taj Pharma India Main Business
Table 141. Taj Pharma India Latest Developments
Table 142. Biomed Lublin Basic Information, Human Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Biomed Lublin Human Tuberculosis Vaccine Product Offered
Table 144. Biomed Lublin Human Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Biomed Lublin Main Business
Table 146. Biomed Lublin Latest Developments
List of Figures
Figure 1. Picture of Human Tuberculosis Vaccine
Figure 2. Human Tuberculosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Tuberculosis Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Tuberculosis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Tuberculosis Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intradermal
Figure 10. Product Picture of Percutaneous
Figure 11. Global Human Tuberculosis Vaccine Sales Market Share by Type in 2021
Figure 12. Global Human Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Human Tuberculosis Vaccine Consumed in Pediatrics
Figure 14. Global Human Tuberculosis Vaccine Market: Pediatrics (2017-2022) & (K Units)
Figure 15. Human Tuberculosis Vaccine Consumed in Adults
Figure 16. Global Human Tuberculosis Vaccine Market: Adults (2017-2022) & (K Units)
Figure 17. Global Human Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Human Tuberculosis Vaccine Revenue Market Share by Application in 2021
Figure 19. Human Tuberculosis Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Human Tuberculosis Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Human Tuberculosis Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Human Tuberculosis Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Human Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Human Tuberculosis Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Human Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Human Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Human Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Human Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Human Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Human Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Human Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Human Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Human Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Human Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Human Tuberculosis Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Human Tuberculosis Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Human Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Human Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Human Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Human Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Human Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Human Tuberculosis Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Human Tuberculosis Vaccine
Figure 63. Industry Chain Structure of Human Tuberculosis Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets